| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.08 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.096 | 0.09 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |